The Mass Torts Unit of Searcy Denney filed an individual lawsuit on December 10, 2010 against the manufacturer of Avandia on behalf of a Jacksonville man, who suffered severe congestive heart failure and worsening of his heart disease after ingesting the insulin sensitizer.

The case was filed in federal court in Pennsylvania, where thousands of Avandia cases from across the country have been consolidated for pre-trial purposes in multi-district proceedings.  The first Avandia trials are scheduled to begin in early 2011.

The focus on the litigation efforts are GlaxoSmithKline’s failure to properly warn consumers and physicians of the risks associated with use of Avandia for more than a decade.  The drug is now a “limited use” medication due to studies showing that it worsens cardiovascular disease and causes heart attacks, strokes, and congestive heart failure.